These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29981455)

  • 1. Prevalence of vancomycin-intermediate Staphylococcus aureus among clinical isolates in Iran: A systematic review and meta-analysis.
    Baseri N; Najar-Peerayeh S; Bagheri Amiri F
    J Glob Antimicrob Resist; 2018 Dec; 15():178-187. PubMed ID: 29981455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.
    Zhang S; Sun X; Chang W; Dai Y; Ma X
    PLoS One; 2015; 10(8):e0136082. PubMed ID: 26287490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.
    Hu J; Ma XX; Tian Y; Pang L; Cui LZ; Shang H
    PLoS One; 2013; 8(9):e73300. PubMed ID: 24069184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran.
    Shekarabi M; Hajikhani B; Salimi Chirani A; Fazeli M; Goudarzi M
    PLoS One; 2017; 12(8):e0183607. PubMed ID: 28854219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.
    Yoo JI; Kim JW; Kang GS; Kim HS; Yoo JS; Lee YS
    J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
    Asadpour L; Ghazanfari N
    Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis.
    Goudarzi M; Seyedjavadi SS; Nasiri MJ; Goudarzi H; Sajadi Nia R; Dabiri H
    Microb Pathog; 2017 Mar; 104():328-335. PubMed ID: 28159661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of vancomycin-resistant Staphylococcus aureus in an intensive care unit in Kerman, Iran.
    Fasihi Y; Saffari F; Mansouri S; Kalantar-Neyestanaki D
    Wien Med Wochenschr; 2018 Mar; 168(3-4):85-88. PubMed ID: 28424995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan--SMART program, 2003.
    Ho CM; Hsueh PR; Liu CY; Lee SY; Chiueh TS; Shyr JM; Tsao SM; Chuang YC; Yan JJ; Wang LS; Wang JH; Ho MW; Tien N; Lu JJ
    Eur J Clin Microbiol Infect Dis; 2010 Apr; 29(4):383-9. PubMed ID: 20155296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
    Kim MN; Hwang SH; Pyo YJ; Mun HM; Pai CH
    J Clin Microbiol; 2002 Apr; 40(4):1376-80. PubMed ID: 11923359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.
    Shariati A; Dadashi M; Moghadam MT; van Belkum A; Yaslianifard S; Darban-Sarokhalil D
    Sci Rep; 2020 Jul; 10(1):12689. PubMed ID: 32728110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
    Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
    J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital.
    Cha HY; Kim HO; Jin JS; Lee JC
    J Microbiol; 2010 Aug; 48(4):533-5. PubMed ID: 20799097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
    da Costa TM; Morgado PG; Cavalcante FS; Damasco AP; Nouér SA; Dos Santos KR
    PLoS One; 2016; 11(8):e0160506. PubMed ID: 27575698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsao SM; Wang WY; Ko WC; Huang CH; Lu CT; Chuang YC; Liu CY; Liao CH; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Chen YH; Lu PL; Thomas CY; Hsueh PR
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):162-7. PubMed ID: 25053202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.
    Saravolatz LD; Pawlak J; Johnson LB
    Clin Infect Dis; 2012 Aug; 55(4):582-6. PubMed ID: 22615331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China.
    Zhang X; Hu Q; Yuan W; Shang W; Cheng H; Yuan J; Zhu J; Hu Z; Li S; Chen W; Hu X; Rao X
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):64-8. PubMed ID: 23876353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.